-
Sector Analysis
NewFeminine Hygiene Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Feminine Hygiene Market Report Overview The feminine hygiene market size was $37.5 billion. The market will grow at a CAGR of more than 4% during 2023-2028. Consumers, especially women, are becoming more conscious about the products they use. The potential long-term effects of exposing intimate areas to synthetic and potentially harmful chemicals are compelling them to seek safer alternatives. Additionally, modern consumers value transparency and are keen on understanding the ingredients in the products they use. Feminine Hygiene Market Outlook,...
-
Thematic Analysis
Social Media in Medical Devices – Thematic Intelligence
Social Media in Medical Devices Thematic Report Overview Social media has proven to impact the medical devices industry significantly. It has allowed patients to get together and discuss treatment options and their experiences within the healthcare system. Social media can help promote medical device awareness and understanding through sharing success stories, testimonials, and educational content. However, consumers’ increased concern about the use of personal data and content moderation will instead see smaller decentralized apps (dApps) become more popular. Several smaller...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-813160 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Solid Tumor Drug Details: BMS-813160 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-813160 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Non-Small Cell Lung Cancer Drug Details: BMS-813160 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-813160 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Metastatic Pancreatic Cancer Drug Details: BMS-813160 is under...
-
Sector Analysis
Cytomegalovirus (CMV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Cytomegalovirus (CMV) Tests Market Report Overview The Cytomegalovirus (CMV) tests market size was valued at $47.2 million in 2023. Cytomegalovirus (CMV) is a widely distributed pathogen that causes congenital infection worldwide. It is a human herpesvirus that can be transmitted through intimate contact with infected bodily fluids and through transplacental transfer, blood transfusion, or organ transplantation. CMV infections are most prevalent in pregnant women, immunocompromised patients, and infants. CMV Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Testosterone in Female Hypoactive Sexual Desire Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Testosterone in Female Hypoactive Sexual Desire Disorder report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Renal Cell Carcinoma Drug Details: BMS-813160 is under development for solid tumor, metastatic...
-
Product Insights
Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Drug Eluting Stents (DES) Pipeline Market Report Overview Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The Drug Eluting Stents (DES) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...